← The Wire
CNTANasdaq
Centessa Pharmaceuticals plc
Pharmaceutical Preparations · X0 · CIK 1847903
Centessa Pharmaceuticals plc pioneers orexin-based neuroscience therapeutics for wakefulness and mood disorders
red 8-K · 90d
$6.15B
Market cap
$40.50
Last close
+0.8%
1D
+1.9%
5D
11.3M
Volume
Price · last 35 sessions+2.0%
May 4L $39.58 · H $40.50Jun 23
123
Total filings
Jun 24, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 13, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFA14AMar 31, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 28, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 21, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSMay 23, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSJun 9, 2022
Insider Activity
In the 90 days to Mar 26, 2026: 3 sold $13.3M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 26, 2026 | Anderson Karen M.Chief People Officer | Sell | 41,076 | $30.12 | $1.2M |
| Mar 26, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 23,998 | $30.00 | $720K |
| Mar 17, 2026 | Anderson Karen M.Chief People Officer | Sell | 10,043 | $28.10 | $282K |
| Mar 16, 2026 | Anderson Karen M.Chief People Officer | Sell | 64,768 | $28.21 | $1.8M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 107,961 | $26.15 | $2.8M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 107,961 | $26.15 | $2.8M |
| Mar 13, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 61,253 | $26.17 | $1.6M |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 12,068 | $27.13 | $327K |
| Mar 13, 2026 | Anderson Karen M.Chief People Officer | Sell | 12,068 | $27.13 | $327K |
| Mar 13, 2026 | Weinhoff Gregory MChief Business Officer | Sell | 11,943 | $27.16 | $324K |
| Feb 2, 2026 | Hussain Iqbal JChief Legal Officer | Sell | 38,951 | $25.15 | $980K |
| Jan 30, 2026 | Hussain Iqbal JChief Legal Officer | Sell | 1,010 | $25.01 | $25K |
| Dec 9, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 7,432 | $28.70 | $213K |
| Dec 9, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 2,568 | $29.21 | $75K |
| Dec 8, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 10,000 | $30.00 | $300K |
| Nov 17, 2025 | Bush Tia LChief Technology & Quality Ofc | Sell | 40,000 | $28.00 | $1.1M |
| Nov 17, 2025 | Hussain Iqbal JGeneral Counsel | Sell | 6,000 | $27.64 | $166K |
| Nov 12, 2025 | Bush Tia LChief Technology & Quality Ofc | Sell | 40,000 | $26.00 | $1.0M |
| Oct 27, 2025 | Accardi Mario AlbertoPresident, Orexin Program | Sell | 8,000 | $25.00 | $200K |
| Oct 15, 2025 | Hussain Iqbal JGeneral Counsel | Sell | 6,000 | $22.41 | $134K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance